vimarsana.com
Home
Live Updates
Ajax Therapeutics Appoints Dr. David Steensma as Chief Medical Officer : vimarsana.com
Ajax Therapeutics Appoints Dr. David Steensma as Chief Medical Officer : vimarsana.com
Ajax Therapeutics Appoints Dr. David Steensma as Chief Medical Officer
NEW YORK--(BUSINESS WIRE)--Aug 23, 2023--
Related Keywords
United States ,
American ,
Kathryn Morris ,
David Steensma ,
Ross Levine ,
Martin Vogelbaum ,
Laurence Joseph Dineen ,
Edwardp Evans ,
Davidp Steensma ,
Harvard Medical School ,
Translational Research ,
Division Of Hematological Malignancies ,
Novartis Institutes For Biomedical Research ,
Dana Farber Cancer Institute ,
Division Of Hematology ,
Department Of Medicine ,
Institute Physician ,
Drug Administration ,
University Of Chicago Pritzker School Medicine ,
Oncology Drug Advisory Committee ,
Leukemia Research ,
American Society Of Hematology ,
Ajax Therapeutics Inc ,
Adult Leukemia Program ,
Yates Network ,
Chief Medical ,
Global Head ,
Novartis Institutes ,
Biomedical Research ,
Business Wire ,
Deputy Physician In Chief ,
Laurence Joseph Dineen Chair ,
Human Oncology ,
Pathogenesis Program ,
Memorial Sloan Kettering Cancer ,
Hematological Malignancies ,
Myelodysplastic Syndromes ,
American Society ,
Pritzker School ,
Ajax Therapeutics ,
Region ,